Clinical Trial Update: Riociguat for Sarcoidosis Associated Pulmonary Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating riociguat for sarcoidosis-associated pulmonary hypertension; the study status is currently unknown and is sponsored by th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Sarcoidosis

Drugs mentioned

• Riociguat (riociguat)

Snippet

Sponsor: University of Cincinnati | Conditions: Sarcoidosis | Phase 4 | Status: UNKNOWN